CGM = continuous glucose monitor(ing)
CGM = continuous glucose monitor(ing)
Make in-the-moment food choices.
The Libre 3 Plus sensor, along with Libre Assist#, can help you predict the impact of food on your glucose**.
Snap.
Take a photo of your meal.
Predict.
Libre Assist# predicts how your food can impact glucose**.
Know.
Get personalized food suggestions†† to help lower glucose impact.
Our 15-day sensor and compatible insulin pumps create one easy§§, single-app experience.
Sign up for a free♢ sensor and get support you can count on.
100% free. No credit card required. No strings attached.
“For anybody that’s newly living with diabetes or who has been living with diabetes for a while, don’t be afraid to make the changes.”
— Jeniese
“My advice to people living with diabetes is to be proactive in your journey towards good health. If you come across a hurdle, stand up for yourself because you’re worth it.”
— Dawn
“I wasn’t managing my diabetes well because I wasn’t doing the fingersticks¶. And now, the FreeStyle Libre 3 Plus sensor is applied to the back of my arm, I pull my smartphone† out, I check my readings, and off we go.”
— Sean
The views expressed should not be used for medical diagnosis or treatment or as a substitute for professional medical advice. Individual symptoms, situations and circumstances may vary.
The FreeStyle Libre 3 system includes the Libre 3 Plus sensor, Libre 3 sensor, Libre 3 app, Libre app, and the Libre 3 reader.
The FreeStyle Libre 2 system includes the Libre 2 Plus sensor, Libre 2 sensor, Libre app, and the Libre 2 reader.
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Coverage and out-of-pocket costs may vary based on your individual insurance plan. Please contact your insurance provider directly to confirm your specific benefits and eligibility.
* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
† The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
‡ Based on the number of pump users having the ability to connect with Libre technology.
§ Based on pharmacy claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus Dexcom CGM systems. Does not include fee-for-service Medicare or fee-for-service Medicaid. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
|| Among patient-applied sensors.
¶ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
# Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions.
** Predicted glucose impact is based on user-provided food data and may differ from actual impact, which depends on sensor readings and factors like activity, stress, medication, and alcohol. For personalized advice, consult your healthcare provider.
†† Personalized food suggestions are based on food preference information inputted by the user.
§§ Based on sensor features including up to 15-day wear period, automatic readings every minute, accuracy data, and single-app setup with AID systems.
References: 1. Fokkert, Marion, et al. “Improved Well-Being and Decreased Disease Burden After 1-Year Use of Flash Glucose Monitoring (FLARE-NL4).” BMJ Open Diabetes Research & Care 7, no. 1 (2019): e000809. https://doi.org/10.1136/bmjdrc-2019-000809. 2. Evans, Mark, Zoë Welsh, and Alexander Seibold. “Reductions in HbA1c With Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-analysis of 75 Real-World Observational Studies.” Diabetes Therapy 13, no. 6 (2022): 1175–1185. https://doi.org/10.1007/s13300-022-01253-9. 3. Alva, Shridhara, et al. “Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.” Journal of Diabetes Science and Technology (2025): 19322968251329364. https://doi.org/10.1177/19322968251329364. 4. Data on file. Abbott Diabetes Care, Inc. 5. FreeStyle Libre 3 User’s Manual. 6. FreeStyle Libre 2 User’s Manual.
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?